Literature DB >> 22184755

Inhibition of NADPH oxidase activation by peptides mapping within the dehydrogenase region of Nox2-A "peptide walking" study.

Iris Dahan1, Shahar Molshanski-Mor, Edgar Pick.   

Abstract

In this study, the "peptide walking" approach was applied to the DH region of Nox2 (residues 288-570) with the purpose of identifying domains of functional importance in the assembly and/or catalytic function of the NADPH oxidase complex of phagocytes. Ninety-one overlapping 15-mer peptides were synthesized to cover the full length of the Nox2 DH region, and these were tested for the ability to interfere with the activation of the oxidase in vitro in two semi-recombinant cell-free systems. The first consisted of phagocyte membranes p47(phox), p67(phox), and Rac1 and an amphiphile; the second was p47(phox)- and amphiphile-free and contained prenylated Rac1. We identified 10 clusters of inhibitory peptides with IC(50) values of 10 μM, all of which were inhibitory, also in the absence of p47(phox). Based on the identification of residues shared by peptides in a particular cluster, we defined 10 functional domains in the Nox2 DH region. One domain corresponded to one FAD-binding subdomain, and four domains overlapped parts of three NADPH-binding subdomains. As expected, most inhibitory peptides acted only when added prior to the completion of oxidase assembly, but peptides associated with two NADPH-binding subdomains were also active after assembly. Kinetic analysis demonstrated that inhibition by peptides was not explained by competition for substrates (FAD, NADPH) but was of a more complex nature: noncompetitive with respect to FAD and uncompetitive with respect to NADPH. We conclude that oxidase-inhibitory peptides, in five out of 10 clusters identified, act by interfering with FAD- and NADPH-related redox reactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22184755     DOI: 10.1189/jlb.1011507

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

Review 1.  Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors.

Authors:  M Eugenia Cifuentes-Pagano; Daniel N Meijles; Patrick J Pagano
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

2.  Inhibiting the Activity of NADPH Oxidase in Cancer.

Authors:  Mariam M Konaté; Smitha Antony; James H Doroshow
Journal:  Antioxid Redox Signal       Date:  2020-04-17       Impact factor: 8.401

Review 3.  Nox NADPH oxidases and the endoplasmic reticulum.

Authors:  Francisco R M Laurindo; Thaís L S Araujo; Thalita B Abrahão
Journal:  Antioxid Redox Signal       Date:  2014-02-26       Impact factor: 8.401

Review 4.  Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.

Authors:  Sebastian Altenhöfer; Kim A Radermacher; Pamela W M Kleikers; Kirstin Wingler; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2014-02-26       Impact factor: 8.401

Review 5.  The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls.

Authors:  Eugenia Cifuentes-Pagano; Daniel N Meijles; Patrick J Pagano
Journal:  Antioxid Redox Signal       Date:  2013-12-14       Impact factor: 8.401

6.  Crystal structures and atomic model of NADPH oxidase.

Authors:  Francesca Magnani; Simone Nenci; Elisa Millana Fananas; Marta Ceccon; Elvira Romero; Marco W Fraaije; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

Review 7.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 8.  Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".

Authors:  Iris Dahan; Edgar Pick
Journal:  Cell Mol Life Sci       Date:  2012-05-06       Impact factor: 9.261

9.  The dehydrogenase region of the NADPH oxidase component Nox2 acts as a protein disulfide isomerase (PDI) resembling PDIA3 with a role in the binding of the activator protein p67 (phox.).

Authors:  Edna Bechor; Iris Dahan; Tanya Fradin; Yevgeny Berdichevsky; Anat Zahavi; Aya Federman Gross; Meirav Rafalowski; Edgar Pick
Journal:  Front Chem       Date:  2015-02-04       Impact factor: 5.221

10.  Strategies Aimed at Nox4 Oxidase Inhibition Employing Peptides from Nox4 B-Loop and C-Terminus and p22 (phox) N-Terminus: An Elusive Target.

Authors:  Gábor Csányi; Patrick J Pagano
Journal:  Int J Hypertens       Date:  2013-03-31       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.